Literature DB >> 28461839

Predictive Factors of Abnormal Circadian Blood Pressure Profile in Recipients of Kidney Transplantation.

Camelia Achim1, Anca Zgura1, Mihai Voiculescu1.   

Abstract

Arterial hypertension (HT) plays an important role and is a major factor in the occurrence and progression of chronic graft nephropathy. We evaluated 24-hour blood pressure (BP) profile in kidney transplant patients to identify factors predictive of abnormal circadian BP profile. BP was measured over a period of 24 hours using a noninvasive automatic device (EC-3H / ABPM) in 40 renal transplant patients (mean age = 37.2±12.2 years, M = 30, mean serum creatinine = 2.0±1.4 mg/dl). They were under the triple immunosuppressive therapy (CsA / Ts + Aza / MMF + PDN). 35 recipients (87.5%) had a nondipper BP profile, with nocturnal values which fell by less than 10% from the daytime BP values. The other 5 containers (12.5%) had normal dipper BP, with lower nighttime values by more than 10% of the daytime BP values. 17/40 recipients (42.5%) had nocturnal BP values higher than daily rates (extreme non-dipper). In none of the patients there has been excessive dipper profile (low nighttime values over 20% less than the diurnal BP). There were no statistically significant differences between the dipper and non-dipper recipients profile in terms of age, gender, creatinine, mean systolic BP (SBP) and daytime SBP, short-term variability in BP and pulse pressure (p>0.05). Factors predictive of a non-dipper BP profile were elevated median 24h BP, median 24 systolic and diastolic blood pressure (DBP), diurnal, nocturnal and 24h pulse rate (p<0.05). In conclusion, the absence of normal nocturnal BP lower values was relatively frequent (87.5%) in renal allograft recipients. In many studied patients nocturnal BP values were higher than the diurnal ones.

Entities:  

Year:  2016        PMID: 28461839      PMCID: PMC5394569     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  8 in total

1.  Ambulatory blood pressure monitoring: technology with a purpose.

Authors:  Michael E Ernst; George R Bergus
Journal:  Am Fam Physician       Date:  2003-06-01       Impact factor: 3.292

Review 2.  Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities.

Authors:  Rajiv Agarwal
Journal:  Kidney Int       Date:  2005-01       Impact factor: 10.612

3.  White-coat hypertension: not guilty when correctly defined.

Authors: 
Journal:  Blood Press Monit       Date:  1998-06       Impact factor: 1.444

4.  A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy.

Authors:  J P Kooman; M H Christiaans; J M Boots; F M van Der Sande; K M Leunissen; J P van Hooff
Journal:  Am J Kidney Dis       Date:  2001-06       Impact factor: 8.860

5.  ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.

Authors:  J Mallion; J Siche; Y Lacourcière
Journal:  J Hum Hypertens       Date:  1999-10       Impact factor: 3.012

Review 6.  Hypertension after renal transplantation.

Authors:  R Dikow; M Zeier; E Ritz
Journal:  Minerva Urol Nefrol       Date:  2003-03       Impact factor: 3.720

7.  Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Hugh C Rayner; Ronald L Pisoni; Juergen Bommer; Bernard Canaud; Erwin Hecking; Francesco Locatelli; Luis Piera; Jennifer L Bragg-Gresham; Harold I Feldman; David A Goodkin; Brenda Gillespie; Robert A Wolfe; Philip J Held; Friedrich K Port
Journal:  Nephrol Dial Transplant       Date:  2004-01       Impact factor: 5.992

8.  Automated ambulatory blood pressure monitoring: clinical utility in the family practice setting.

Authors:  Rod J Marchiando; Michael P Elston
Journal:  Am Fam Physician       Date:  2003-06-01       Impact factor: 3.292

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.